News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Allenex AB: XM-ONE Receives US Patent Protection



10/13/2011 9:32:45 AM

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: AbSorber, part of Allenex (STO:ALNX) group, focusing on antibody detection before transplantation has received US patent protection for its cross match-test XM-ONE®. The patent, with the title Methods of Donor Specific Crossmatching, was granted by the US Patent and Trademark Office. AbSorber has previously approved patent for XM-ONE® in other regions including the European Union, India, Australia and Canada. “The fact that our patent was approved in the U.S. is of great value to us. It is a strong confirmation that the product is unique and has a high degree of innovation. Currently we are working hard in collaboration with leading laboratories in the U.S. to establish clinical use of the product”, said Anders Karlsson, CEO Allenex.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES